Keywords: bentley, revenues, jump, 3rd, qtr, pharmaceuticals, self-described
Bentley's revenues jump 21% for 3rd qtr
Article | 15 November 2004
Bentley Pharmaceuticals, a self-described technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
